Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Maxwell Roger Lloyd, M.D.

Concepts (75)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperammonemia12020760.680 Why?
Protein-Energy Malnutrition120201870.670 Why?
Bariatric Surgery120209400.370 Why?
Obesity, Morbid1202012040.340 Why?
Breast Neoplasms72023207740.270 Why?
Cyclin-Dependent Kinase 4220235350.210 Why?
Legionella12021300.200 Why?
Lung Abscess12021420.200 Why?
Empyema, Pleural12021620.190 Why?
Cyclin-Dependent Kinase 6120223220.170 Why?
Breast Neoplasms, Male120202100.170 Why?
Pleural Effusion120213380.160 Why?
Protein Kinase Inhibitors3202355220.140 Why?
Comprehensive Health Care120161270.130 Why?
Leukemia, Myeloid, Acute2202134970.130 Why?
Enteral Nutrition120207630.120 Why?
DNA, Neoplasm1201717580.100 Why?
Receptor, erbB-21202224100.100 Why?
Myelodysplastic Syndromes1202113510.100 Why?
Genomics3202256920.100 Why?
Pneumonia1202121170.090 Why?
Artificial Intelligence1202221870.080 Why?
Cell Cycle Proteins1202034440.080 Why?
Neoplasm Metastasis1201748390.070 Why?
Drug Resistance, Neoplasm1202051630.060 Why?
Neoplasm Recurrence, Local1202091850.050 Why?
Chest Tubes120211500.050 Why?
Retinoblastoma Binding Proteins12020970.040 Why?
Receptors, Steroid120201550.040 Why?
Genes, p53120217550.040 Why?
Stem Cell Niche120213420.040 Why?
Humans1120237420880.040 Why?
Antineoplastic Agents12020136550.040 Why?
Female820233795920.040 Why?
Drainage1202111400.030 Why?
Neoplasm Staging22020110010.030 Why?
Gene Dosage1201712510.030 Why?
Proto-Oncogene Proteins p21(ras)1202016830.030 Why?
Receptors, Progesterone1201610970.030 Why?
Proto-Oncogene Proteins c-akt1202025020.020 Why?
Bone Marrow1202129410.020 Why?
Tumor Suppressor Protein p531202129480.020 Why?
Prognosis22022290100.020 Why?
Ubiquitin-Protein Ligases1202018600.020 Why?
Postoperative Care1201614840.020 Why?
Kaplan-Meier Estimate1202065340.020 Why?
Antigens, Neoplasm1201719830.020 Why?
Tumor Microenvironment1202135640.020 Why?
Hematopoietic Stem Cells1202133810.020 Why?
DNA Mutational Analysis1201741870.020 Why?
Receptors, Estrogen1201621860.020 Why?
Mastectomy1201617890.020 Why?
Chemotherapy, Adjuvant1201634710.020 Why?
Biopsy1202067560.020 Why?
Mammaplasty1201611950.020 Why?
Mutation22021297170.020 Why?
Disease Progression12023132560.020 Why?
Retrospective Studies22023770980.010 Why?
Reproducibility of Results12022198620.010 Why?
Cell Line, Tumor12020166650.010 Why?
Software1201744340.010 Why?
Adult320212137120.010 Why?
Practice Guidelines as Topic1201672760.010 Why?
Aged220201629440.010 Why?
Aged, 80 and over12020576830.010 Why?
Treatment Outcome12022629660.010 Why?
Middle Aged220202131270.010 Why?
Prostatic Neoplasms12017110390.010 Why?
Mice12021810450.010 Why?
Young Adult12020563500.010 Why?
Cohort Studies12016404500.010 Why?
Prospective Studies12017531870.010 Why?
Adolescent12020856490.010 Why?
Male220203495380.010 Why?
Animals120211685610.010 Why?
Lloyd's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (75)
Explore
_
Co-Authors (52)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.